Bronstein, Gewirtz & Grossman, LLC Investigates Potential Claims Against Dentsply Sirona Inc.
New York, NY – In a recent press release on March 2, 2025, Bronstein, Gewirtz & Grossman, LLC announced that it is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. (Dentsply or the Company) (NASDAQ: XRAY). The investigation concerns securities transactions that occurred prior to May 6, 2021, and are still held by investors.
Background on Dentsply Sirona Inc.
Dentsply Sirona Inc. is a leading dental and medical technology company, headquartered in York, Pennsylvania, USA. The Company operates through two business segments: Dental and Medical. Dentsply Sirona Dental provides innovative, high-quality and cost-effective solutions for the dental industry, including equipment, consumables, software, and services. Dentsply Sirona Medical focuses on producing and supplying medical devices and equipment for various medical fields, such as orthopedics and neurosurgery.
The Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating whether Dentsply and certain of its executives and directors have violated the Securities Exchange Act of 1934 through alleged securities fraud. Specifically, the firm is looking into whether the Company issued materially false and misleading statements and/or failed to disclose material information to investors.
Impact on Individual Investors
If you purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, you may be able to assist in the investigation by providing information about your transactions. Investors who wish to learn more about the investigation and their potential legal rights and remedies can visit the firm’s site at bgandg.com/XRAY. The investigation may result in various outcomes, including potential lawsuits against the Company and its executives, settlements, or other forms of compensation for affected investors.
Global Implications
The potential securities fraud investigation against Dentsply Sirona Inc. may have far-reaching implications for the dental and medical technology industry as a whole. Investors’ confidence in the sector could be affected, potentially leading to decreased investor interest and a negative impact on stock prices. Moreover, if the investigation uncovers significant misconduct, it could lead to increased regulatory scrutiny and potential changes to industry regulations.
Conclusion
The investigation by Bronstein, Gewirtz & Grossman, LLC into potential securities fraud at Dentsply Sirona Inc. has significant implications for individual investors and the broader dental and medical technology industry. If you are an investor in Dentsply and are interested in learning more about the investigation and your potential legal rights and remedies, please visit bgandg.com/XRAY for more information.
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Dentsply Sirona Inc.
- The investigation concerns securities transactions prior to May 6, 2021.
- Individual investors who held Dentsply securities during that time are encouraged to visit bgandg.com/XRAY for more information.
- The investigation could lead to lawsuits, settlements, or other forms of compensation for affected investors.
- The potential implications for the dental and medical technology industry are significant, including decreased investor confidence and increased regulatory scrutiny.
